Mustafa Abdul Karim1, Nadeen Al-Baz1, Sami Ouanes1, Ali Khalil1, Ahmed H Assar2, Abdulkarim Alsiddiqi2, Zeinab Dabbous3, Mahmoud Zirie3, Peter Woodruff1,2, Rayaz A Malik2, Peter M Haddad4,5,6. 1. Department of Psychiatry, Hamad Medical Corporation, Doha, Qatar. 2. Weill Cornell Medicine-Qatar, Ar-Rayyan, Qatar. 3. Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar. 4. Department of Psychiatry, Hamad Medical Corporation, Doha, Qatar. Phaddad@hamad.qa. 5. College of Medicine, Qatar University, Doha, Qatar. Phaddad@hamad.qa. 6. Division of Psychology and Mental Health, School of Health Sciences, University of Manchester, Manchester, UK. Phaddad@hamad.qa.
Abstract
BACKGROUND: Patients with schizophrenia are at least twice as likely to develop diabetes mellitus compared to the general population. This is of significance in Qatar given the high prevalence of obesity and diabetes. Furthermore, the lifespan of people with schizophrenia is shortened by approximately 15 years, partly due to long-term microvascular and macrovascular complications. High quality diabetes care can significantly reduce morbidity and mortality. We assessed the level of diabetes care delivered to patients in Qatar with schizophrenia and diabetes compared to those with diabetes alone. METHODS: We performed a retrospective chart review of patients with diabetes mellitus with (n = 73) and without (n = 73) schizophrenia. Demographic information and electronic medical records were reviewed to determine adherence to American Diabetes Association standards of diabetes care in the last 6 and 12 months. Optimal diabetes care was defined as having completed glycated hemoglobin (HbA1c), lipid profile and retinal examination within 12 months. RESULTS: Optimal diabetes care was significantly lower in patients with schizophrenia and diabetes compared to diabetes alone [26.0% (n = 19/73) vs 52.1% (n = 38/73), p = 0.002]. Patients with diabetes and schizophrenia were also significantly less likely to have had body mass index recorded within 6 months (p = 0.008) and HbA1c (p = 0.006), lipid profile (p = 0.015), estimated glomerular filtration rate (eGFR) (p = 0.001) and order for retinal examination (p = 0.004) over 12 months. After adjusting for multiple comparisons, only assessment of eGFR (p = 0.01) and order for retinal examination (p = 0.04) remained significant. CONCLUSION: Patients in Qatar with schizophrenia and diabetes, receive sub-optimal diabetes care compared to those with diabetes alone.
BACKGROUND:Patients with schizophrenia are at least twice as likely to develop diabetes mellitus compared to the general population. This is of significance in Qatar given the high prevalence of obesity and diabetes. Furthermore, the lifespan of people with schizophrenia is shortened by approximately 15 years, partly due to long-term microvascular and macrovascular complications. High quality diabetes care can significantly reduce morbidity and mortality. We assessed the level of diabetes care delivered to patients in Qatar with schizophrenia and diabetes compared to those with diabetes alone. METHODS: We performed a retrospective chart review of patients with diabetes mellitus with (n = 73) and without (n = 73) schizophrenia. Demographic information and electronic medical records were reviewed to determine adherence to American Diabetes Association standards of diabetes care in the last 6 and 12 months. Optimal diabetes care was defined as having completed glycated hemoglobin (HbA1c), lipid profile and retinal examination within 12 months. RESULTS: Optimal diabetes care was significantly lower in patients with schizophrenia and diabetes compared to diabetes alone [26.0% (n = 19/73) vs 52.1% (n = 38/73), p = 0.002]. Patients with diabetes and schizophrenia were also significantly less likely to have had body mass index recorded within 6 months (p = 0.008) and HbA1c (p = 0.006), lipid profile (p = 0.015), estimated glomerular filtration rate (eGFR) (p = 0.001) and order for retinal examination (p = 0.004) over 12 months. After adjusting for multiple comparisons, only assessment of eGFR (p = 0.01) and order for retinal examination (p = 0.04) remained significant. CONCLUSION:Patients in Qatar with schizophrenia and diabetes, receive sub-optimal diabetes care compared to those with diabetes alone.
Authors: Joseph Firth; Najma Siddiqi; Ai Koyanagi; Dan Siskind; Simon Rosenbaum; Cherrie Galletly; Stephanie Allan; Constanza Caneo; Rebekah Carney; Andre F Carvalho; Mary Lou Chatterton; Christoph U Correll; Jackie Curtis; Fiona Gaughran; Adrian Heald; Erin Hoare; Sarah E Jackson; Steve Kisely; Karina Lovell; Mario Maj; Patrick D McGorry; Cathrine Mihalopoulos; Hannah Myles; Brian O'Donoghue; Toby Pillinger; Jerome Sarris; Felipe B Schuch; David Shiers; Lee Smith; Marco Solmi; Shuichi Suetani; Johanna Taylor; Scott B Teasdale; Graham Thornicroft; John Torous; Tim Usherwood; Davy Vancampfort; Nicola Veronese; Philip B Ward; Alison R Yung; Eoin Killackey; Brendon Stubbs Journal: Lancet Psychiatry Date: 2019-07-16 Impact factor: 27.083
Authors: Marc DE Hert; Christoph U Correll; Julio Bobes; Marcelo Cetkovich-Bakmas; Dan Cohen; Itsuo Asai; Johan Detraux; Shiv Gautam; Hans-Jurgen Möller; David M Ndetei; John W Newcomer; Richard Uwakwe; Stefan Leucht Journal: World Psychiatry Date: 2011-02 Impact factor: 49.548
Authors: H C B Nørgaard; H Schou Pedersen; M Fenger-Grøn; M Vestergaard; M Nordentoft; T M Laursen; O Mors Journal: Scand J Prim Health Care Date: 2019-07-12 Impact factor: 2.581